Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings

Accept

;

Corporate profile

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.

Corporate videos


“Although few people die of pain, many still die in pain, while even more live in pain. We will leave no stone unturned to help these patients.”

Gabriel Baertschi

Chief Executive Officer, Grünenthal

As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to people living with pain worldwide. Strong ongoing partnerships with leading healthcare and development organisations bring our new products to life. We are a fully integrated pharmaceutical company that offers support along the entire value chain – from drug development through to commercialisation.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 29 countries across Europe, Latin America and the US. Our products are available in more than 100 countries. In 2020, Grünenthal employed around 4,500 people and achieved sales of € 1.3 bn.

Strong and capable team
4,500

employees worldwide

Solid revenue base
1.3

billion euro in 2020

Commercial presence in
29

countries across Europe, Latin America and the US

Products sold in about
100

countries

International network
2

research centres, our Research Unit in Aachen and our Innovation Hub in Boston

Production capacities
5

manufacturing sites in Europe and Latin America

Our unique commit­ment 

Pain is a huge burden. It impacts patients – as well as their families, friends, caregivers and society as a whole. As a global leader in pain management for nearly 50 years, we are driven to seek new solutions to relieve pain.

 

Responsibility

At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact for society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.

Global capabilities

Although firmly rooted in Germany, today we are very much a growing global business: since spreading our wings beyond Germany in the 1960s, we have continued to grow steadily.

 

 

Pipeline

In our quest to improve the lives of even more patients in need, we enrich our expertise in pain management with a complementary diversification into devices and technologies.